M. Kamil, M., Jabarah, M.A.-.H. and A.l. Jasim, N. (2023) “Immunogenicity of the biosimilar CT-P13 infliximab or the original infliximab in Iraqi patients with Ankylosing spondylitis does not correlate with their demographic characteristics”, Journal of the Faculty of Medicine Baghdad, 64(4), pp. 261–267. doi:10.32007/jfacmedbagdad.6441969.